EP Patent

EP4337184A1 — Ppar-agonists for use in the treatment of liver failure

Assigned to Genfit SA · Expires 2024-03-20 · 2y expired

What this patent protects

The invention relates to compounds for use in the treatment of liver failure.

USPTO Abstract

The invention relates to compounds for use in the treatment of liver failure.

Drugs covered by this patent

Patent Metadata

Patent number
EP4337184A1
Jurisdiction
EP
Classification
—
Expires
2024-03-20
Drug substance claim
No
Drug product claim
No
Assignee
Genfit SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.